← FDA ENFORCEMENT
D-0332-2026Class I

HANDELNINE GLOBAL LLC

Recalling firm
HANDELNINE GLOBAL LLC
Product type
Drug
Status
Ongoing
Report date
2026-02-11
Distribution
Product was distributed to one customer in NY.
Firm state
NJ
Product quantity
4 bottles /30 capsules each
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPA
Reason for recall

CGMP Deviations: product found to contain lead.

Product description

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

Code / lot info

Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028

Other recalls SPEQ maps to Risk Management & CAPA
2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.
See all Risk Management & CAPA recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.